TMAO
Trimethylamine N-oxide (TMAO) is a compound produced with the help of gut bacteria from nutrients such as choline in eggs and carnitine in beef. Fish and seafood also contain TMAO directly.
What it means in practice
Production of TMAO by gut bacteria has been proposed as a mechanism linking foods such as beef and eggs with the development of atherosclerosis, and TMAO has gained attention as a candidate biomarker for cardiovascular disease [1].
That reading is contested. Landfald and colleagues point out that fish and seafood contain considerable amounts of TMAO and are generally accepted as good for the heart, a paradox they say has been neglected [1]. A 2026 narrative review of glycerophosphocholine (GPC, also called alpha-glycerophosphocholine [2]) describes TMAO as a metabolite associated with atherosclerosis progression but says its adverse effect remains debatable [3].
Why it matters when reading nootropics research
Choline and carnitine are among the nutrients gut bacteria turn into TMAO [1], so studies of these supplements can measure it. In a randomized crossover study of six healthy men, co-funded by the food manufacturer HiPP-Werk Georg Hipp OHG, researchers measured blood TMAO after single doses of four choline supplements, including alpha-GPC [2]. A study in healthy volunteers tracked TMAO in plasma and urine after acetyl-L-carnitine and carnitine supplements [4]. The alpha-GPC and acetyl-L-carnitine pages report what these studies found.
When a page mentions TMAO, read it as a change in a blood marker, not a measured health outcome. As noted above, whether a higher TMAO level carries any risk is still debated [3][1].
References
- Landfald B, Valeur J, Berstad A, et al. Microbial trimethylamine-N-oxide as a disease marker: something fishy?. Microb Ecol Health Dis. 2017.
- Böckmann KA, Franz AR, Minarski M, et al. Differential metabolism of choline supplements in adult volunteers. Eur J Nutr. 2022.
- Chen S, Ohkubo T, Yanaka N, et al. A Friend or Foe: Understanding the Physiological Significance, Therapeutic Uses, and Potential Risks of Glycerophosphocholine-A Narrative Review. Nutrients. 2026.
- Krims-Davis K, Ozola M, Razzivina V, et al. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism. Mol Nutr Food Res. 2025.